title: A paradoxical outcome after ablation in patients with paroxysmal atrial fibrillation: only overweight patients might benefit from an enhanced PVI strategy.
authors.affiliation: Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, HangZhou, China.
authors.forename: YaXun
authors.initials: Y
authors.lastname: Sun
authors.forename: SongQun
authors.initials: S
authors.lastname: Huang
authors.forename: RuHong
authors.initials: R
authors.lastname: Jiang
authors.forename: Xia
authors.initials: X
authors.lastname: Sheng
authors.forename: Qiang
authors.initials: Q
authors.lastname: Liu
authors.forename: Hong
authors.initials: H
authors.lastname: He
authors.forename: YiZhou
authors.initials: Y
authors.lastname: Xu
authors.forename: SriJoy
authors.initials: S
authors.lastname: Mahapatra
authors.forename: GuoSheng
authors.initials: G
authors.lastname: Fu
authors.forename: ChenYang
authors.initials: C
authors.lastname: Jiang
mesh_terms: D000368:Aged; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery*; D017115:Catheter Ablation / Q000639:trends; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D050177:Overweight / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery*; D011667:Pulmonary Veins / Q000473:pathology / Q000601:surgery*; D012189:Retrospective Studies
keywords: Ablation; Adenosine triphosphate; Atrial fibrillation; BMI; Pulmonary veins